Bioz vs CytoReason
Bioz vs CytoReason, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bioz is on 47/100 and CytoReason on 68/100.
Where each one leads
Bioz
- domain rating: 70/100 against 40/100
- headcount growth: +23.4% against +13.7%
- LinkedIn following: 22,525 against 12,830
CytoReason
- our overall score: 68/100 against 47/100
- headcount: 116 against 55
- funding raised: $128M against $10.0M
At a glance
| Measure | Bioz | CytoReason |
|---|---|---|
| What it is | Bioz is an AI search engine for life science experimentation, helping scientists find validated and cost-effective products. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Insights, Knowledge, AI Search Engine | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2013 | 2016 |
| Headquarters | Palo Alto, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Bioz | CytoReason |
|---|---|---|
| Employees | 55 | 116 |
| Headcount growthLast 12 months | +23.4% | +13.7% |
| Total funding | $10.0M | $128M |
| Latest round | Series A | Series B |
| LinkedIn followers | 22,525 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bioz | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 47/100 | 68/100 |
| Traction | 53/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 36/100 | 30/100 |
| Quality | 58/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 70/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bioz | CytoReason |
|---|---|---|
| Hosting | AWS | Not detected |
| Analytics | Not detected | Segment |
Bioz vs CytoReason: common questions
Which is better, Bioz or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Bioz and CytoReason compare on the numbers?
Bioz leads on domain rating (70/100 against 40/100), headcount growth (+23.4% against +13.7%), LinkedIn following (22,525 against 12,830). CytoReason leads on our overall score (68/100 against 47/100), headcount (116 against 55), funding raised ($128M against $10.0M).
Read the full Bioz review and pricing or the CytoReason review and pricing. You can also browse other Bioz alternatives we track.